# Apnimed Inc. (APMD)

Source: https://www.quantisnow.com/company/APMD
Generated: 2026-11-08T17:25:01.655Z

- Ticker: APMD
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2026
- SEC CIK: 0001745648
- Website: https://apnimed.com/

## About

Apnimed is a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases. We believe the introduction of once-nightly oral drugs has the potential to expand diagnosis and the reach of treatment for people with OSA. We believe that people with OSA would benefit from having multiple treatment options with differing mechanisms to more fully address the heterogeneity of OSA's disease pathophysiology. Apnimed envisions a new era where novel oral therapies simplify intervention and expand the reach of diagnosis and treatment.

## Latest APMD news and filings

- 2026-11-05 21:05 UTC [Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)](https://www.quantisnow.com/insight/apnimed-inc-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6776158)
- 2026-11-04 14:00 UTC [SEC Schedule 13G] [SEC Form SCHEDULE 13G filed by Apnimed Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-apnimed-inc-6771684)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/APMD
- Earnings history: https://www.quantisnow.com/earnings/APMD
- Dividend history: https://www.quantisnow.com/dividends/APMD
- Insider transactions: https://www.quantisnow.com/insiders/APMD
- Options chain: https://www.quantisnow.com/options/APMD
- SEC 8-K filings only: https://www.quantisnow.com/company/APMD/8-k
- RSS and alerts for APMD: https://www.quantisnow.com/docs/rss-feeds.md